☆ 4.3 Letter

L1CAM Is Not a Reliable Diagnostic Biomarker for Distinguishing Supratentorial Ependymomas, ZFTA Fusion-Positive From Other Central Nervous System Tumors

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2022)

Related references

Note: Only part of the references are listed.
Article Oncology

Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas

Tuyu Zheng et al.

Summary: Supratentorial ependymomas can be categorized into tumors with ZFTA-RELA or YAP1 fusions, fusion-negative subependymomas, and other tumors that cannot be classified. ZFTA acts as a partner gene in oncogenic fusions with various histologic features, with GLI2 identified as a key regulator of tumorigenesis in these tumors. Targeting GLI2 with arsenic trioxide shows potential therapeutic benefits for ZFTA fusion-positive tumors.

CANCER DISCOVERY (2021)

Add to Collection
Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Add to Collection
Article Pathology

Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology

Marco Gessi et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Add to Collection
Article Oncology

C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin

Prit Benny Malgulwar et al.

JOURNAL OF NEURO-ONCOLOGY (2018)

Add to Collection
Article Oncology

Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling

Dominique Figarella-Branger et al.

NEURO-ONCOLOGY (2016)

Add to Collection
Article Multidisciplinary Sciences

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma

Matthew Parker et al.

NATURE (2014)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.